These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34867939)

  • 21. Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs.
    McNeil BD
    Neurosci Lett; 2021 Apr; 751():135746. PubMed ID: 33610674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
    Baldo BA
    Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
    Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
    Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cell conditions and drug allergy: when to suspect and how to manage.
    Olivieri B; Ghilarducci A; Nalin F; Bonadonna P
    Curr Opin Allergy Clin Immunol; 2024 Aug; 24(4):195-202. PubMed ID: 38814742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2).
    Kumar M; Singh K; Duraisamy K; A Allam A; Ajarem J; Kwok Chong Chow B
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.
    Roy S; Chompunud Na Ayudhya C; Thapaliya M; Deepak V; Ali H
    J Allergy Clin Immunol; 2021 Aug; 148(2):293-308. PubMed ID: 33957166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roxithromycin inhibits compound 48/80-induced pseudo-allergy via the MrgprX2 pathway both in vitro and in vivo.
    Zhang Y; Wang J; Ge S; Zeng Y; Wang N; Wu Y
    Cell Immunol; 2020 Dec; 358():104239. PubMed ID: 33129497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
    Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mast-cell-specific receptor mediates Iopamidol induced immediate IgE-independent anaphylactoid reactions.
    Jiang W; Hu S; Che D; An H; Liu R
    Int Immunopharmacol; 2019 Oct; 75():105800. PubMed ID: 31401386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
    Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
    Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions.
    Hamamura-Yasuno E; Iguchi T; Kumagai K; Tsuchiya Y; Mori K
    Sci Rep; 2020 Sep; 10(1):16146. PubMed ID: 32999394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
    McNeil BD; Pundir P; Meeker S; Han L; Undem BJ; Kulka M; Dong X
    Nature; 2015 Mar; 519(7542):237-41. PubMed ID: 25517090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRGPRX2 in drug allergy: What we know and what we do not know.
    Kolkhir P; Ali H; Babina M; Ebo D; Sabato V; Elst J; Frischbutter S; Pyatilova P; Maurer M
    J Allergy Clin Immunol; 2023 Feb; 151(2):410-412. PubMed ID: 36089079
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.
    Ogasawara H; Furuno M; Edamura K; Noguchi M
    J Leukoc Biol; 2019 Nov; 106(5):1069-1077. PubMed ID: 31299111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity.
    Ebo DG; Van der Poorten ML; Elst J; Van Gasse AL; Mertens C; Bridts C; Garvey LH; Horiuchi T; Sabato V
    Br J Anaesth; 2021 Jan; 126(1):e27-e29. PubMed ID: 33153719
    [No Abstract]   [Full Text] [Related]  

  • 36. Mas-Related G Protein-Coupled Receptor-X2 and Its Role in Non-immunoglobulin E-Mediated Drug Hypersensitivity.
    Chompunud Na Ayudhya C; Ali H
    Immunol Allergy Clin North Am; 2022 May; 42(2):269-284. PubMed ID: 35469618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation.
    Takamori A; Izawa K; Kaitani A; Ando T; Okamoto Y; Maehara A; Tanabe A; Nagamine M; Yamada H; Uchida S; Uchida K; Isobe M; Hatayama T; Watanabe D; Ando T; Ide T; Matsuzawa M; Maeda K; Nakano N; Tamura N; Ikeda K; Ebihara N; Shimizu T; Ogawa H; Okumura K; Kitaura J
    J Allergy Clin Immunol; 2019 Mar; 143(3):1231-1235.e12. PubMed ID: 30414859
    [No Abstract]   [Full Text] [Related]  

  • 38. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
    Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
    J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Historical Anecdotes and Breakthroughs of Histamine: From Discovery to Date.
    Charitos IA; Castellaneta F; Santacroce L; Bottalico L
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):801-814. PubMed ID: 32727338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
    Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
    Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.